Haemonetics (HAE) Free Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Haemonetics | 3.18 Bn | 2.93 Bn | 198.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 48.75% |
| Dec 27, 2025 | 8.91% |
| Sep 27, 2025 | 38.56% |
| Jun 28, 2025 | 27.08% |
| Mar 29, 2025 | 23.06% |
| Dec 28, 2024 | -9.77% |
| Sep 28, 2024 | 14.03% |
| Jun 29, 2024 | -42.54% |
| Mar 30, 2024 | 52.66% |
| Dec 30, 2023 | -20.35% |
| Sep 30, 2023 | 58.96% |
| Jul 1, 2023 | 35.67% |
| Apr 1, 2023 | -18.62% |
| Dec 31, 2022 | 4.15% |
| Oct 1, 2022 | 3.27% |
| Jul 2, 2022 | -16.44% |
| Apr 2, 2022 | 11.68% |
| Jan 1, 2022 | -0.30% |
| Oct 2, 2021 | 2.40% |
| Jul 3, 2021 | -31.27% |
| Apr 3, 2021 | -19.21% |
| Dec 26, 2020 | 47.65% |
| Sep 26, 2020 | 66.50% |
| Jun 27, 2020 | 17.86% |
| Mar 28, 2020 | 1.24% |
| Dec 28, 2019 | 87.70% |
| Sep 28, 2019 | 58.57% |
| Jun 29, 2019 | 24.78% |
| Mar 30, 2019 | -20.31% |
| Dec 29, 2018 | -0.58% |
| Sep 29, 2018 | -9.05% |
| Jun 30, 2018 | -74.47% |
| Mar 31, 2018 | 20.70% |
| Dec 30, 2017 | 34.83% |
| Sep 30, 2017 | 44.01% |
| Jul 1, 2017 | 38.69% |
| Apr 1, 2017 | 1.34% |
| Dec 31, 2016 | 18.27% |
| Oct 1, 2016 | 8.52% |
| Jul 2, 2016 | -11.73% |
| Apr 2, 2016 | 3.86% |
| Dec 26, 2015 | -25.83% |
| Sep 26, 2015 | -40.54% |
| Jun 27, 2015 | -54.60% |
| Mar 28, 2015 | 5.88% |
| Dec 27, 2014 | -16.38% |
| Sep 27, 2014 | -16.06% |
| Jun 28, 2014 | -48.35% |